IPQ Inside the global regulatory dialogue

Pandemic Stresses Increase FDA Attention on Risk Management Plans for Drug Shortage Prevention and Mitigation

Nov 15th, 2020

Please Log in to print the full article

CDER’s McNally Offers Insights on RMP Use at PDA/FDA Conference With the CARES  implementation deadline about to arrive and a significant amount of experience having been gained in managing the coronavirus pandemic, CDER Office of...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications